BIOMARKERS New biomarker for Sjogren's syndrome-time to treat patients

Frans G. M. Kroese, Hendrika Bootsma*

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

8 Citaten (Scopus)

Samenvatting

Recent progress in our understanding of the pathogenesis of primary Sjgren's syndrome (pSS) and the development of indices to measure disease activity in patients with this condition, offer us ample possibilities for treatment with biologic DMARDs. New biomarkers further aid selection of patients with pSS for appropriate treatment options.

Originele taal-2English
Pagina's (van-tot)570-572
Aantal pagina's4
TijdschriftNATURE REVIEWS RHEUMATOLOGY
Volume9
Nummer van het tijdschrift10
DOI's
StatusPublished - okt-2013

Citeer dit